INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,000 | -28.6% | 1,507 | -32.6% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 2,237 | +183.9% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 788 | +6.8% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 738 | -68.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 2,308 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 2,308 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -50.0% | 2,308 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | +50.0% | 2,308 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | -20.0% | 2,308 | +5.3% | 0.00% | – |
| Q1 2018 | $5,000 | +25.0% | 2,191 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -20.0% | 2,191 | -43.5% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 3,876 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -53.8% | 3,876 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | +160.0% | 3,876 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -16.7% | 3,876 | +6.5% | 0.00% | – |
| Q3 2016 | $6,000 | +500.0% | 3,641 | +317.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |